↓ Skip to main content

Meta‐analysis: Anticholinergics, but not β‐agonists, Reduce Severe Exacerbations and Respiratory Mortality in COPD

Overview of attention for article published in Journal of General Internal Medicine, May 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

policy
2 policy sources
twitter
1 X user
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
92 Dimensions

Readers on

mendeley
56 Mendeley
connotea
1 Connotea
Title
Meta‐analysis: Anticholinergics, but not β‐agonists, Reduce Severe Exacerbations and Respiratory Mortality in COPD
Published in
Journal of General Internal Medicine, May 2006
DOI 10.1111/j.1525-1497.2006.00507.x
Pubmed ID
Authors

Shelley R. Salpeter, Nicholas S. Buckley, Edwin E. Salpeter

Abstract

Anticholinergics and beta2-agonists have generally been considered equivalent choices for bronchodilation in chronic obstructive pulmonary disease (COPD).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Germany 1 2%
Unknown 54 96%

Demographic breakdown

Readers by professional status Count As %
Other 8 14%
Researcher 8 14%
Student > Bachelor 7 13%
Student > Ph. D. Student 6 11%
Student > Master 6 11%
Other 16 29%
Unknown 5 9%
Readers by discipline Count As %
Medicine and Dentistry 39 70%
Agricultural and Biological Sciences 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Chemistry 2 4%
Nursing and Health Professions 1 2%
Other 4 7%
Unknown 6 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2022.
All research outputs
#3,561,374
of 25,374,647 outputs
Outputs from Journal of General Internal Medicine
#2,483
of 8,173 outputs
Outputs of similar age
#8,479
of 86,555 outputs
Outputs of similar age from Journal of General Internal Medicine
#34
of 97 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,173 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.1. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 86,555 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.